These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30072879)

  • 1. Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice.
    Torres ERS; Akinyeke T; Stagaman K; Duvoisin RM; Meshul CK; Sharpton TJ; Raber J
    Front Behav Neurosci; 2018; 12():140. PubMed ID: 30072879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.
    Al-Sweidi S; Morissette M; Di Paolo T
    J Steroid Biochem Mol Biol; 2016 Jul; 161():84-91. PubMed ID: 26873133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
    Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
    J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Al-Sweidi S; Morissette M; Di Paolo T
    J Neuroendocrinol; 2012 Nov; 24(11):1375-85. PubMed ID: 22672467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP.
    Tan Y; Xu Y; Cheng C; Zheng C; Zeng W; Wang J; Zhang X; Yang X; Wang J; Yang X; Nie S; Cao X
    Front Pharmacol; 2020; 11():183. PubMed ID: 32180729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Related functions of mGlu4 and mGlu8.
    Davis MJ; Duvoisin RM; Raber J
    Pharmacol Biochem Behav; 2013 Oct; 111():11-6. PubMed ID: 23948069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain.
    Pu Y; Chang L; Qu Y; Wang S; Zhang K; Hashimoto K
    Aging (Albany NY); 2019 Sep; 11(17):6915-6929. PubMed ID: 31479418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
    Yang C; Wang W; Deng P; Wang X; Zhu L; Zhao L; Li C; Gao H
    CNS Neurosci Ther; 2023 Dec; 29(12):3815-3828. PubMed ID: 37334756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.
    Hwang CJ; Choi DY; Jung YY; Lee YJ; Yun JS; Oh KW; Han SB; Oh S; Park MH; Hong JT
    Horm Behav; 2016 Apr; 80():19-29. PubMed ID: 26836768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson's disease in a mouse model.
    Hong GU; Cho JW; Kim SY; Shin JH; Ro JY
    Toxicol Appl Pharmacol; 2018 Nov; 358():10-22. PubMed ID: 30195017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Paraquat, Dextran Sulfate Sodium, and Irradiation on Behavioral and Cognitive Performance and the Gut Microbiome in A53T and A53T-L444P Mice.
    Chaklai A; O'Neil A; Goel S; Margolies N; Krenik D; Perez R; Kessler K; Staltontall E; Yoon HKE; Pantoja M; Stagaman K; Kasschau K; Unni V; Duvoisin R; Sharpton T; Raber J
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
    Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
    Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RESP18 deficiency has protective effects in dopaminergic neurons in an MPTP mouse model of Parkinson's disease.
    Su J; Wang H; Yang Y; Wang J; Li H; Huang D; Huang L; Bai X; Yu M; Fei J; Huang F
    Neurochem Int; 2018 Sep; 118():195-204. PubMed ID: 29964075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Pflibsen L; Stang KA; Sconce MD; Wilson VB; Hood RL; Meshul CK; Mitchell SH
    J Neurosci Res; 2015 Dec; 93(12):1849-64. PubMed ID: 26332770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
    Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
    Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT.
    Bentea E; Sconce MD; Churchill MJ; Van Liefferinge J; Sato H; Meshul CK; Massie A
    Neurosci Lett; 2015 Apr; 593():1-6. PubMed ID: 25766755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.